Extensive Cardiac Involvement in ANCA-Associated Vasculitis Presenting With Severe Aortic Regurgitation and Atrioventricular Block Authors: David Gabriel David-Pardo, Raúl Eduardo Reyes-T, Geronimo Luna, Isabella Gómez, Javier Rojas-Marulanda, Yilmar Alexander Meza-González, Hugo Herrera Castillo, Carlos Obando López, Claudia P. Jaimes-Castellanos, Juan Felipe Vasquez-Rodriguez Published: 2026 ABSTRACT BackgroundAntineutrophil cytoplasmic antibody (ANCA)–associated vasculitis rarely presents with severe inflammatory cardiac involvement. Valvuloaortic disease with high-grade atrioventricular block is particularly uncommon.Case SummaryA 53-year-old woman was referred with a presumptive diagnosis of non–ST-segment elevation myocardial infarction. Coronary angiography showed no obstructive epicardial coronary artery disease. Multimodality imaging demonstrated severe aortic regurgitation, inflammatory valvuloaortic thickening with cusp retraction, moderate pericardial effusion, nonischemic septal late gadolinium enhancement, and progressive high-grade atrioventricular block. Rheumatologic assessment supported myeloperoxidase-positive ANCA-associated vasculitis. She underwent mechanical aortic valve replacement and cardiac resynchronization therapy pacemaker implantation. Rituximab was subsequently initiated as immunosuppressive therapy. Histopathology showed active inflammatory valvulitis without detectable microorganisms.DiscussionThis case highlights a rare but clinically important inflammatory cardiac phenotype and underscores the value of multimodality imaging and multidisciplinary evaluation.Take-Home MessageANCA-associated vasculitis may rarely present as multicompartment cardiac involvement and should be considered in severe inflammatory valvuloaortic disease with conduction abnormalities. Visual SummaryClinical Presentation, Diagnostic Work-Up, and Management of MPO-Positive ANCA-Associated Vasculitis With Severe Inflammatory Valvuloaortic Disease, Severe Aortic Regurgitation, and High-Grade Atrioventricular BlockANCA = antineutrophil cytoplasmic antibody; AV = atrioventricular; MPO = myeloperoxidase; p-ANCA = perinuclear antineutrophil cytoplasmic antibody. Clinical Presentation, Diagnostic Work-Up, and Management of MPO-Positive ANCA-Associated Vasculitis With Severe Inflammatory Valvuloaortic Disease, Severe Aortic Regurgitation, and High-Grade Atrioventricular Block ANCA = antineutrophil cytoplasmic antibody; AV = atrioventricular; MPO = myeloperoxidase; p-ANCA = perinuclear antineutrophil cytoplasmic antibody. History of Presentation A 53-year-old woman presented with a 4-day history of intermittent chest pain at rest. On the day of admission, she developed severe retrosternal pain radiating to the mandible and left upper extremity, associated with diaphoresis, dyspnea, and nausea. She described the pain as predominantly oppressive, although occasionally sharp. She denied fever.Take-Home Messages•In patients with chest pain, troponin elevation, severe aortic regurgitation, and progressive conduction disease, especially in the setting of systemic inflammatory features, ANCA-associated vasculitis should be considered as a potential unifying diagnosis.•Multimodality imaging and multidisciplinary evaluation can uncover inflammatory valvuloaortic involvement, define the mechanism of cardiac injury, and support timely combined surgical and immunosuppressive treatment. Take-Home Messages •In patients with chest pain, troponin elevation, severe aortic regurgitation, and progressive conduction disease, especially in the setting of systemic inflammatory features, ANCA-associated vasculitis should be considered as a potential unifying diagnosis.•Multimodality imaging and multidisciplinary evaluation can uncover inflammatory valvuloaortic involvement, define the mechanism of cardiac injury, and support timely combined surgical and immunosuppressive treatment. •In patients with chest pain, troponin elevation, severe aortic regurgitation, and progressive conduction disease, especially in the setting of systemic inflammatory features, ANCA-associated vasculitis should be considered as a potential unifying diagnosis. In patients with chest pain, troponin elevation, severe aortic regurgitation, and progressive conduction disease, especially in the setting of systemic inflammatory features, ANCA-associated vasculitis should be considered as a potential unifying diagnosis. •Multimodality imaging and multidisciplinary evaluation can uncover inflammatory valvuloaortic involvement, define the mechanism of cardiac injury, and support timely combined surgical and immunosuppressive treatment. Multimodality imaging and multidisciplinary evaluation can uncover inflammatory valvuloaortic involvement, define the mechanism of cardiac injury, and support timely combined surgical and immunosuppressive treatment. At the referring institution, electrocardiography showed no ischemic ST-segment changes. However, given the elevation in cardiac troponin levels, she was transferred to our institution for invasive coronary evaluation, with a presumptive diagnosis of non–ST-segment elevation myocardial infarction. On arrival, she was hemodynamically stable. Physical examination revealed a diastolic murmur at the aortic area and bounding peripheral pulses, consistent with Corrigan pulse. Examination of the extremities showed bilateral swan-neck deformities of the index fingers without active synovitis. Past Medical History The patient had a history of autoimmune inflammatory disease, diagnosed in 2019 and initially classified as rheumatoid arthritis, for which she had been treated with methotrexate and low-dose prednisolone. Over time, her course became notable for recurrent ocular inflammation, sinonasal involvement, serositis, and articular manifestations, raising suspicion for an underlying systemic vasculitic disorder. In the months preceding admission, she reported xerophthalmia and episodic bilateral knee arthralgia. Differential Diagnosis The initial differential diagnosis included non–ST-segment elevation myocardial infarction, inflammatory myopericardial disease, and significant aortic valve pathology. Non–ST-segment elevation myocardial infarction was initially suspected because of the ischemic quality of the chest pain and elevated cardiac troponin levels. However, the intermittent sharp component of the pain, together with the history of autoimmune inflammatory disease and clinical features suggestive of vasculitis, raised concern for an inflammatory pericardial or myocardial process. Significant aortic valve disease was also considered in light of the diastolic murmur and bounding peripheral pulses on physical examination. Investigations Initial electrocardiogram showed significant conduction abnormalities, including first-degree atrioventricular block (AVB) (PR interval: 300 ms), left anterior fascicular block, and right bundle branch block morphology (Figure 1). Troponin I levels increased from 56 to 260 ng/L, and chest radiography showed cardiomegaly. Because the patient presented with chest pain and troponin elevation, coronary angiography was performed and demonstrated no obstructive epicardial coronary artery disease, redirecting the diagnostic work-up away from an atherothrombotic acute coronary syndrome.Figure 1Initial Electrocardiogram Showing First-Degree Atrioventricular Block (PR Interval, 300 ms), Left Anterior Fascicular Block, and Right Bundle Branch Block Morphology Initial Electrocardiogram Showing First-Degree Atrioventricular Block (PR Interval, 300 ms), Left Anterior Fascicular Block, and Right Bundle Branch Block Morphology Given the diastolic murmur and abnormal peripheral pulses, transthoracic echocardiography demonstrated severe native aortic regurgitation. Key parameters confirming severity are shown in Figure 2 and Video 1. The left ventricle was severely dilated, with mild systolic dysfunction (left ventricular ejection fraction: 45%), and the aortic root was dilated.Figure 2Multimodal Echocardiographic Assessment of Severe Aortic Regurgitation(A) Continuous-wave Doppler of the aortic regurgitation jet showing a markedly reduced pressure half-time of 193 ms (yellow arrow). (B) Proximal isovelocity surface area of the aortic regurgitation jet, with a measured radius of 10 mm after color Doppler scale adjustment (double-headed arrow). (C) Color Doppler demonstrating holodiastolic flow reversal in the descending thoracic aorta (yellow asterisk). (D) Pulsed-wave Doppler of the descending thoracic aorta showing holodiastolic flow reversal, with an end-diastolic velocity of 25 cm/s (white arrow). Multimodal Echocardiographic Assessment of Severe Aortic Regurgitation (A) Continuous-wave Doppler of the aortic regurgitation jet showing a markedly reduced pressure half-time of 193 ms (yellow arrow). (B) Proximal isovelocity surface area of the aortic regurgitation jet, with a measured radius of 10 mm after color Doppler scale adjustment (double-headed arrow). (C) Color Doppler demonstrating holodiastolic flow reversal in the descending thoracic aorta (yellow asterisk). (D) Pulsed-wave Doppler of the descending thoracic aorta showing holodiastolic flow reversal, with an end-diastolic velocity of 25 cm/s (white arrow). To better define the mechanism of regurgitation, transesophageal echocardiography showed a tricuspid aortic valve with marked thickening of the cusp free margins, most prominent in the noncoronary cusp, resulting in restricted leaflet motion, incomplete coaptation, and severe central aortic regurgitation (Videos 2 and 3). Thickening extended to the dilated aortic root (43 mm at the sinuses of Valsalva) and proximal ascending aorta (Figure 3), suggesting inflammatory valvuloaortic involvement with possible aortitis.Figure 3Transesophageal Echocardiography Demonstrating Marked Thickening of the Aortic Root Wall (Asterisks) With Associated Dilation (Arrow) Measuring 43 mm Transesophageal Echocardiography Demonstrating Marked Thickening of the Aortic Root Wall (Asterisks) With Associated Dilation (Arrow) Measuring 43 mm Given the elevated troponin level in the absence of obstructive coronary artery disease, cardiac magnetic resonance (CMR) was performed to evaluate a possible mechanism of myocardial infarction with nonobstructive arteries and to assess for myocardial or pericardial inflammation. It confirmed left ventricular dilatation with reduced systolic function (left ventricular ejection fraction: 35%) and aortic root dilatation, with imaging features also supporting severe aortic regurgitation. CMR also showed moderate pericardial effusion without pericardial thickening or pericardial late gadolinium enhancement, and linear midmyocardial septal late gadolinium enhancement in the absence of myocardial edema, findings not diagnostic of active myocarditis (Figure 4).Figure 4Cardiac Magnetic Resonance Showing Linear Midmyocardial Late Gadolinium Enhancement in the Basal Septum (Dashed Arrow), in the Absence of Myocardial Edema, Along With Mild Pericardial Effusion (Solid Arrow) Cardiac Magnetic Resonance Showing Linear Midmyocardial Late Gadolinium Enhancement in the Basal Septum (Dashed Arrow), in the Absence of Myocardial Edema, Along With Mild Pericardial Effusion (Solid Arrow) During hospitalization, conduction disease progressed from marked first-degree AVB to intermittent advanced AVB, including Mobitz II, 2:1 AVB, and complete AVB, documented on Holter monitoring. The unusual combination of nonobstructive coronary arteries, severe aortic regurgitation, pericardial involvement, nonischemic septal late gadolinium enhancement, valvuloaortic thickening, progressive conduction abnormalities, and a history of autoimmune inflammatory disease prompted rheumatologic reassessment. Rheumatoid factor and anti–cyclic citrullinated peptide antibodies were negative, making rheumatoid arthritis less likely as the primary diagnosis. Antinuclear antibodies were positive at a titer of 1:160 with a fine dense speckled pattern; however, anti–double-stranded DNA antibodies, extractable nuclear antigen panel, and antiphospholipid antibodies were negative, with normal complement levels, arguing against systemic lupus erythematosus. Treponemal serology was nonreactive, making syphilitic aortitis unlikely. Immunologic evaluation revealed perinuclear antineutrophil cytoplasmic antibody (p-ANCA) positivity (1:320), elevated anti-myeloperoxidase antibody levels (67.8 chemiluminescent units [CU]; reference range, 0-20 CU), and low anti-PR3 titers. In the setting of recurrent peripheral ulcerative keratitis, chronic sinonasal disease, serositis, and articular involvement, these findings supported myeloperoxidase (MPO)–positive ANCA-associated vasculitis as the unifying diagnosis, with cardiac involvement as part of the disease spectrum. Management Management focused on severe aortic regurgitation, inflammatory valvuloaortic abnormalities, and progressive conduction disease. Although CMR demonstrated basal septal late gadolinium enhancement in close anatomical proximity to the conduction system, the findings were nonspecific and did not fulfill criteria for active myocarditis, as no myocardial edema was identified. Therefore, the enhancement was interpreted cautiously as possibly reflecting subacute or chronic inflammatory injury, fibrosis, or otherwise nonspecific tissue damage not fully characterizable by standard CMR sequences. Nevertheless, these imaging findings did not outweigh the clinical significance of the preoperative high-grade AVB, or the anticipated risk of further conduction deterioration after aortic valve replacement. In this context, and considering the CMR-derived left ventricular ejection fraction of 35%, the multidisciplinary team decided to proceed with concomitant cardiac resynchronization therapy pacemaker implantation at the time of surgical valve replacement, given the high likelihood of long-term pacing dependency. Intraoperative inspection revealed a tricuspid aortic valve with a whitish gross appearance and markedly thickened, edematous cusps, particularly at their basal attachments, without gross vegetations (Figure 5, Video 4). The mitroaortic curtain was also thickened and edematous, extending toward the trigonal region.Figure 5Intraoperative Views Showing a Tricuspid Aortic Valve With a Whitish Appearance and Markedly Thickened Cusps Intraoperative Views Showing a Tricuspid Aortic Valve With a Whitish Appearance and Markedly Thickened Cusps Histopathology demonstrated stromal degeneration with mixed inflammatory infiltrates composed of neutrophils, lymphocytes, and plasma cells, consistent with active valvular inflammation (Figure 6). No bacteria or fungi were identified, and intraoperative tissue cultures and blood cultures were negative. Although nonspecific, the broader clinicopathologic context strongly favored sterile inflammatory valvulitis related to ANCA-associated disease. The overall phenotype was considered consistent with probable organ-threatening ANCA-associated vasculitis, and escalation to rituximab was planned in addition to continued glucocorticoid therapy.Figure 6Hematoxylin and Eosin–Stained Section of the Aortic Valve Showing Dense Neutrophilic Inflammatory Infiltrate, Consistent With Active Valvulitis Hematoxylin and Eosin–Stained Section of the Aortic Valve Showing Dense Neutrophilic Inflammatory Infiltrate, Consistent With Active Valvulitis Outcome and Follow-Up The postoperative course was favorable. Early follow-up transthoracic echocardiography showed a normally functioning mechanical aortic prosthesis, mild residual left ventricular systolic dysfunction (left ventricular ejection fraction: 50%), and no recurrent significant pericardial effusion. Heart failure therapy and anticoagulation were continued. At the 1-year follow-up, the patient was at NYHA functional class I status, without angina or palpitations. Discussion This case highlights a diagnostically challenging presentation of MPO-positive ANCA-associated vasculitis with cardiac involvement affecting multiple adjacent structures. What initially appeared to be a non–ST-segment elevation myocardial infarction was later reframed after coronary angiography excluded obstructive epicardial coronary disease and multimodality imaging demonstrated severe aortic regurgitation, valvuloaortic thickening, pericardial involvement, nonischemic septal scar, and progressive atrioventricular conduction disease. Taken together, these findings supported an inflammatory rather than isolated ischemic mechanism. Cardiac involvement in ANCA-associated vasculitis is uncommon but increasingly recognized and may include pericardial, myocardial, coronary, valvular, and conduction system abnormalities.1 Valvular involvement is rare, and severe aortic regurgitation has been described in only a limited number of reports.2, 3, 4 In our patient, the combination of cusp thickening, aortic root involvement, mitroaortic curtain edema, pericardial effusion, and advanced AVB suggests inflammatory extension within the valvuloaortic region. This interpretation is anatomically plausible and is consistent with prior reports linking ANCA-associated vasculitis to severe aortic valvular dysfunction and conduction disturbances.3,5 Although CMR did not show findings diagnostic of active myocarditis, the basal septal late gadolinium enhancement provided a plausible anatomical substrate for progressive conduction disturbance. At the same time, focal or subclinical inflammation not captured by standard CMR sequences, as well as possible microvascular inflammatory component related to the vasculitis process, cannot be excluded. Histopathology further strengthened the diagnosis. Although no granulomatous or necrotizing pattern was identified, the valve showed active inflammatory injury, cultures were negative, and no microorganisms were detected. This is in keeping with prior reports in which cardiac or valvular ANCA-associated vasculitis showed inflammatory or postinflammatory changes rather than a pathognomonic vasculitic pattern.3,4 Therefore, in the appropriate clinicoserologic context, the absence of classic histopathologic features should not exclude ANCA-associated cardiac involvement. Rheumatoid valvular disease was considered less likely because rheumatoid serologies were negative and no rheumatoid nodular pattern was identified on histopathology, whereas Behçet disease was less favored by the absence of a typical mucocutaneous phenotype and the overall MPO-ANCA-positive disease context. Prior glucocorticoid exposure may also have attenuated histopathologic specificity.6 From a phenotypic standpoint, MPO-positive ANCA-associated vasculitis was considered the most coherent unifying diagnosis. Although MPO-ANCA is more commonly associated with microscopic polyangiitis, the patient's recurrent ocular and sinonasal manifestations suggested overlap with a granulomatosis-with-polyangiitis–like phenotype within the broader ANCA-associated vasculitis spectrum.7,8 From a management perspective, severe aortic regurgitation with left ventricular remodeling and high-grade AVB justified surgery, whereas the overall phenotype supported remission-induction therapy with glucocorticoids and rituximab. The timing of surgery relative to induction immunosuppression was guided by the presence of advanced structural valvular damage requiring timely correction and by preoperative rheumatologic reassessment, which did not identify a clear reason to defer valve replacement for induction therapy. Prior reports suggest that once inflammatory valve damage is established, immunosuppression alone may be insufficient and surgical intervention may still be required.2,3,9 Conclusions This case highlights ANCA-associated vasculitis as a potential cause of multicompartment inflammatory cardiac involvement, including severe valvuloaortic disease and progressive conduction abnormalities. In patients with severe aortic regurgitation and systemic inflammatory features, early multimodality imaging and multidisciplinary evaluation may help establish the diagnosis and guide timely surgical and immunosuppressive treatment. Funding Support and Author Disclosures The authors have reported that they have no relationships relevant to the contents of this paper to disclose.